Specifically, CRYBG1, RRM2, and MMP1 showed higher levels in the RA group than in the normal group, whereas SLC19A2 showed significantly lower expression (Figure 8D), consistent with observation in the training cohort. This evidence concerns the gene RRM2 and rheumatoid arthritis.